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ABSTRACT
This manuscript reports a case of intestinal toxemia botulism in an adult with recently 
diagnosed metastatic colon cancer in whom botulism symptoms began 23 days after hospital 
admission. Representing the rarest form of botulism presentation in clinical practice, this 
infectious disease may have developed due to a cluster of predisposing factors that favored 
Clostridium botulinum colonization and the endogenous production of neurotoxins, among 
which are previous use of broad-spectrum antibiotics and colon changes related to the 
development of the neoplasia. This case highlights the importance of considering intestinal 
toxemia botulism in the differential diagnosis of a patient presenting with symmetrical 
descending flaccid paralysis, since immediate treatment with botulinum antitoxin may 
improve clinical outcomes.
KEYWORDS: Adult intestinal toxemia botulism. Neuropathy. Intestinal colonization. 
Diagnosis. Neuromuscular junction. Symmetrical descending flaccid paralysis. Clostridium 
botulinum.
INTRODUCTION
Botulism is a paralytic neurotoxin-induced disease caused by Clostridium 
botulinum1-3. This clinical entity is capable of affecting individuals at any age1. 
Classically, botulism has an acute presentation4, and its spectrum includes four 
main types of naturally occurring disease, numbered as follows: intestinal (or 
hidden) infection with in situ production of toxins; this is most commonly reported 
in infants (I), than in adults (II); wound botulism (III); the disease caused by 
contaminated food, the so-called foodborne botulism (IV) which is characterized by 
the ingestion of preformed toxins2,3,5,6. Two other forms of the disease are represented 
by (V) iatrogenic botulism, during the use of botulinum toxin either for therapeutic 
or cosmetic indications, and (VI) inhalation botulism, caused by aerosolized toxins7,8. 
Adult intestinal toxemia botulism (II), also called infant-like botulism9, is the rarest 
form10, characterized by the ingestion of spores, their intestinal germination and 
the intraluminal production of neurotoxins1,9,11,12. 
Typically characterized by bilateral cranial neuropathy followed by descending 
flaccid symmetric paralysis and potential ventilatory impairment, the differential 
diagnosis of botulism can be challenging, as the disease may share some features 
with several other clinical entities. Moreover, the differential diagnosis includes 
some atypical clinical presentations of botulism itself4,8,13. Considering the high 
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mortality rates related to this form of botulism, ranging from 
40-50% in untreated cases13, prompt diagnosis is crucial 
for the specific treatment with the antitoxin, besides the 
supportive care4,8,10,13.
Herein we report a case of sporadic adult intestinal 
toxemia botulism initiated after a 23-day hospitalization 
period, in a patient admitted due to a recently diagnosed 
colon cancer.
CASE REPORT
A 63-year-old Brazilian man was hospitalized due 
to severe symptomatic anemia (hemoglobin level of 
4 g/dL). His previous clinical history revealed no known 
comorbidities, no wounds or recent skin infections, and no 
regular use of any medication.
Computed tomography images showed irregular wall 
thickness in the hepatic angle of the colon suggestive of 
primary tumor, with a mass extending longitudinally by 
13 cm, with areas of necrosis. The right lobe of the liver had 
undergone secondary enlargement due to the presence of a 
large, heterogeneous and hypovascular expansive formation 
on the liver surface measuring 12.0 x 15.5 x 10.5 cm, and 
at least three other similar hepatic lesions, presumably 
metastatic. Furthermore, bilaterally randomly distributed 
pulmonary nodules with soft tissue densities were found, 
associated with paratracheal, subcarinal, right pulmonary 
hilum and left gastric chain lymph nodes enlargement. The 
endoscopic study revealed a stenotic lesion in the second 
portion of the duodenum, with tumor characteristics, and 
fragments were collected for anatomopathological study. 
Colonoscopy showed a great vegetative stenotic lesion 
on the right flexure of the colon, which was biopsied. As 
both endoscopic biopsies were described as inconclusive, 
an ultrasound-guided biopsy of the hepatic lesion 
was performed, leading to the diagnosis of metastatic 
adenocarcinoma that had probably originated in the 
colon. This result has motivated the chemotherapy with 
5-fluorouracil and leucovorin.
After fourteen days of hospitalization, the patient 
started fever, hypotension responsive to intravenous 
fluids and sinus tachycardia. The diagnosis of sepsis 
with undefined focus was then established, with the 
administration of broad-spectrum antimicrobial therapy 
(piperacillin associated with tazobactam), with fast 
recovery. Nine days later, the patient presented with 
abdominal pain, prostration, vomiting, frontal headache, 
dizziness, blurred vision, photophobia and difficulties 
in speaking. Within a 24-hour interval, he progressed 
with anarthria and bilateral ophthalmoparesis and ptosis, 
followed by agitation and respiratory distress finally 
progressing to cardiac arrest in pulseless electrical 
activity, probably due to hypoxemia. Cardiopulmonary 
resuscitation was successfully performed for five minutes, 
with the need of intubation and maintenance in mechanical 
ventilation. Subsequently, a brain computed tomography 
revealed no signs suggestive of intracerebral expanding 
lesions, or ischemic and hemorrhagic stroke. In addition, 
lumbar puncture did not show significant alterations 
(Figure 1).
Figure 1 - Representative sequence of events in the reported case reported since hospital admission. CPR: cardiopulmonary 
resuscitation CT: computed tomography.
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As soon as sedation was suspended, the patient regained 
consciousness, obeying simple commands such as moving 
hands and feet. From this moment, the neurological 
examination progressively deteriorated, with development 
of symmetrical descending flaccid tetraparesia and loss 
of deep tendon reflexes, with the consciousness status 
still preserved. Mechanical ventilation was maintained as 
the patient did not show signs that allowed extubation. A 
four-limb electroneuromyography, performed five days 
after the onset of symptoms, revealed intense myopathic 
findings evidenced by the high recruitment of motor units, 
with slight incremental response. Neither signs of acute or 
chronic denervation nor sensitive alterations were observed. 
Regarding the nervous conduction, the compound muscle 
action potentials (CMAPs) were found reduced in the 
proximal muscles, with M waves of low voltage, showing 
impairment of motor function.
 Considering the possibility of a variant of the Guillain-
Barré syndrome, a 4-session course of plasmapheresis 
was performed, without any improvement concerning 
the neurological pattern. As the clinical presentation 
could also be associated with adult intestinal toxemia 
botulism, blood and stool samples were collected for 
specific neurotoxins identification, with the botulinum 
antitoxin only available sixteen days after the onset of 
symptoms, which was then administered. Sequentially, the 
patient developed intestinal obstruction and progressive 
worsening in renal function, evolving to death forty-six 
days after hospital admission (Figure 1). Post-mortem 
examination showed botulinum neurotoxin type A both 
in serum and stool samples, by the bioassay method with 
intraperitoneal inoculation of mice (the standard method 
for detecting these toxins5,7, because of its high sensitivity 
and specificity6,8).
DISCUSSION
The clinical report described herein brings a case of 
adult intestinal colonization by C. botulinum, secondary 
to the intestinal germination of spores and intraluminal 
production of neurotoxins, progressing to intestinal toxemia 
botulism, an even rarer condition1,9,10,12,14.
Pathophysiologically, botulinum neurotoxins, some of 
the most potent of all natural toxins known6-8,15, bind to 
receptors in the presynaptic membrane of neuromuscular 
junctions2,5 leading to the irreversible blockage of exocytosis 
of acetylcholine in the synaptic cleft8, also affecting the 
sympathetic and parasympathetic nervous systems2. Thus, 
autonomic signs and symptoms may be present4, such as 
constipation, dry mouth, postural hypotension, pupillary 
alterations and urinary retention1,2,11.
The pathophysiological sequence of events observed in 
botulism leads to symmetric cranial nerve impairment in 
the early stages, clinically manifested by dizziness, blurred 
or double vision, difficulties in speaking and swallowing, 
followed by descending symmetrical weakness of voluntary 
muscles (initially in the upper limbs and sequentially in the 
lower limbs), possibly involving respiratory distress and 
the need of ventilatory support2,5. Mentation and sensory 
systems are not usually affected, although cases of sensory 
impairment have been reported2.
When it comes to adults, intestinal toxemia botulism is 
described as a diagnostic challenge10, with only a few cases 
reported worldwide. Indeed, this rarity may contribute to 
possible delays in adequate diagnosis and the establishment 
of proper treatment12.
In the current case, we were able to rule out foodborne 
botulism because this condition has a relatively short 
incubation period (3-5 days)5 or even shorter, from two 
to 24 hours4, and the patient had been hospitalized for 23 
days when symptoms appeared. Moreover, the patient did 
not present any other evidence of ingestion of contaminated 
food or a wound source of toxins. Finally, there were no 
concomitant cases at the hospital, making the possibility 
of a form of botulism other than the intestinal toxemia 
very unlikely. 
Under normal conditions, ingested spores are eliminated 
without germinating or producing toxins, so that in most 
cases the disease does not manifest5. Intestinal toxemia 
botulism in adults is a variant of the childhood botulism, 
as the spores found it easier to proliferate in the presence 
of gastrointestinal abnormalities. In the case reported here, 
the patient had been diagnosed with probable metastatic 
colon cancer, one of the different gastrointestinal conditions 
cited in the literature that may favor the colonization of 
C. botulinum. Other predisposing abnormalities are bowel 
surgery, inflammatory bowel disease9, achlorhydria or 
recent antibiotic treatment2,11,12, and possibly anatomical 
abnormalities such as Meckel’s diverticulum1. Most of these 
examples are well-recognized conditions that can disrupt the 
balanced competition between the normal bowel flora and 
the normally fastidious Clostridia species, in favor of the 
latter5,10. Considering the possibility of sporadic botulism 
in a patient without a clear compatible history of food or 
wound source of botulinum toxins, the identification of 
excretion of toxins in stool samples is a critical determinant 
for the diagnosis5. Actually, the diagnosis of intestinal 
toxemia botulism depends on the repeated identification, 
for prolonged periods (from 2 to 119 days, according to 
previous reports), of viable C. botulinum or neurotoxins in 
clinical samples, besides clinical features that suggest this 
infection12. Despite the fact that in the current report only 
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one set of samples was positive for C. botulinum toxins, 
considering that the patient died soon after the first samples 
collection (the results for confirmation were released post-
mortem), no other form of botulism seems plausible. 
The standard treatment for botulism is based on the 
early administration of the trivalent (A, B and E) botulinum 
antitoxin13. The antitoxin must be administrated soon after 
clinical suspicion of botulism made8, since even mouse 
bioassays may not confirm the diagnosis, justifying why 
waiting for laboratory confirmation to initiate treatment is 
described as a serious mistake14.
In summary, the present case, a rare occurrence of 
intestinal toxemia botulism in an adult patient, reinforces 
the importance of considering the possibility of botulism 
as a differential diagnosis in patients with symmetric 
cranial nerves impairment and descending symmetrical 
weakness. Undoubtedly, early diagnosis, supportive care 
and the administration of botulinum antitoxin are crucial 
for achieving better clinical outcomes.
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